share_log

Jacobio Pharmaceuticals Doses Non-Small Cell Lung Cancer Patient With Tumor Medication in China Phase 2A Trial

Jacobio Pharmaceuticals Doses Non-Small Cell Lung Cancer Patient With Tumor Medication in China Phase 2A Trial

雅可比奧製藥公司在中國腫瘤藥物治療中的劑量非小細胞肺癌患者的2A期試驗
MT Newswires ·  2022/08/31 21:02

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論